Search clinical trials for: protein target
Total 25982 results
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedRenal Cell CarcinomaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia A | Hemophilia B
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
AmgenCompleted
-
Cell GenesysCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedNeoplasm Metastasis | Colorectal CancerUnited States
-
National Institute of Neurological Disorders and...Completed
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompleted
-
Callisto PharmaceuticalsCompletedMultiple MyelomaUnited States
-
The Cleveland ClinicTerminatedCoronary Artery Disease | Atherosclerosis | Inflammatory ResponseUnited States
-
Epeius BiotechnologiesTerminatedPancreatic CancerUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedHead and Neck CancerHong Kong, Singapore
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
AstraZenecaCompleted
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
AstraZenecaCompletedGefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerHead and Neck NeoplasmsFinland
-
NSABP Foundation IncAstraZenecaCompletedBreast NeoplasmsUnited States
-
Medical University of GdanskCompletedProteinuria | Chronic Kidney Disease
-
Medical University of GdanskCompletedProteinuria | Chronic Kidney Disease
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia B | Allergic ReactionsFrance, Italy, United States, Austria, Belgium, Spain, United Kingdom, Canada, Germany
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Shanghai Municipal Health BureauUnknownProteinuria | Angiotensin II Type 1 Receptor Blockers | Chronic Kidney Insufficiency | Angiotensin-Converting Enzyme InhibitorsChina
-
Peking UniversityCompletedAmyotrophic Lateral SclerosisChina
-
Assistance Publique - Hôpitaux de ParisCompletedProtein-Energy MalnutritionFrance
-
Dartmouth-Hitchcock Medical CenterCelgene CorporationCompletedAmyotrophic Lateral Sclerosis | ALSUnited States
-
AO Clinical Investigation and Publishing DocumentationOssacur Inc.Terminated
-
NovartisCompletedSeasonal Allergic RhinitisUnited Kingdom
-
Solvay PharmaceuticalsCompleted
-
Shiraz University of Medical SciencesCompletedDiabetic Nephropathy | Chronic Kidney Disease | Diabetes Type 2Iran, Islamic Republic of
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAmyotrophic Lateral SclerosisUnited States
-
Institut de Recherches Cliniques de MontrealTerminatedHypertension | Type 2 Diabetes | AlbuminuriaCanada
-
Isfahan University of Medical SciencesShahid Beheshti University of Medical SciencesCompleted
-
NovaceaSchering-PloughSuspended
-
Gruppo Italiano MEsoteliomaUnknown
-
University of WuerzburgUnknownMultiple MyelomaGermany, Austria
-
Johann Wolfgang Goethe University HospitalUnknownPhiladelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid LeukemiaGermany
-
Inflabloc PharmaceuticalsCompletedAn Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's DiseaseCrohn's DiseaseUnited States, Canada
-
Kamada, Ltd.CompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Recoly N.V.CompletedHaemophilia ARussian Federation
-
Eli Lilly and CompanyCompletedSepsis | HypotensionFrance, United States
-
Sheba Medical CenterUnknownLeukemia, Myeloid, Philadelphia-PositiveIsrael
-
PfizerCompletedVenous ThrombosisAustralia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia
-
SanofiCompleted
-
Speedel Pharma Ltd.Quintiles, Inc.CompletedChronic Kidney Failure | Vascular Graft OcclusionUnited States